PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34545658-0	2021	MK-6, a novel not-alpha IL-2, elicits a potent antitumor activity by improving the effector to regulatory T cell balance.	menaquinone 6	0-4	interleukin 2	Homo sapiens	24-28	
34545658-5	2021	MK-6 induced comparable cell-growth potential towards IL-2Rbetagamma-positive T cells but was far less efficient in vitro Treg proliferation and STAT5 activation.	menaquinone 6	0-4	signal transducer and activator of transcription 5A	Homo sapiens	145-150	
34545658-9	2021	Tumor-infiltrating leukocytes analysis revealed that albumin-fused MK-6 increased the ratio of effector CD8+ T-to-CD4+ Treg cells.	menaquinone 6	67-71	CD8a molecule	Homo sapiens	104-107	
34545658-9	2021	Tumor-infiltrating leukocytes analysis revealed that albumin-fused MK-6 increased the ratio of effector CD8+ T-to-CD4+ Treg cells.	menaquinone 6	67-71	CD4 molecule	Homo sapiens	114-117